References
- Speiser P, Azziz R, Baskin L, et al. Congenital adrenal hyperplasia due to steroid 21-hydroxylase deficiency: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2010;95:4133–60.
- New M, Abraham M, Gonzalez B, et al. Genotype-phenotype correlation in 1,507 families with congenital adrenal hyperplasia owing to 21-hydroxylase deficiency. Proc Natl Acad Sci USA. 2013;110:2611–6.
- Nimkarn S, Gangishetti PK, Yau M, et al. 21-Hydroxylase-deficient congenital adrenal hyperplasia. In: Pagon RA, Adam MP, Ardinger HH, et al. editors. GeneReviews®. Seattle (WA): University of Washington; 1993. Available at: http://www.ncbi.nlm.nih.gov/books/NBK1171/.
- Ezquieta B, Alonso M, Alvarez E, et al. Should 21-hydroxylase deficiency genotyping be considered in assisted reproductive technology programs? Fertil Steril. 2007;88:1437.e5–11.
- Fernández-Balsells MM, Muthusamy K, Smushkin G, et al. Prenatal dexamethasone use for the prevention of virilization in pregnancies at risk for classical congenital adrenal hyperplasia because of 21-hydroxylase (CYP21A2) deficiency: a systematic review and meta-analyses. Clin Endocrinol (Oxf.) 2010;73:no–444.
- Wedell A, Luthman H. Steroid 21-hydroxylase (P450c21): a new allele and spread of mutations through the pseudogene. Hum Genet. 1993;91:236–40.
- Schouten J, McElgunn C, Waaijer R, et al. Relative quantification of 40 nucleic acid sequences by multiplex ligation-dependent probe amplification. Nucleic Acids Res. 2002;30. Available at: http://www.ncbi.nlm.nih.gov/pubmed/?term=Schouten+JP+et+al.+(2002)+Relative+quantification+of+40+nucleic+acid+sequences+by+multiplex+ligationdependent+probe+amplification+Nucleic+Acids+Res+30%2C+e57.
- White P, Speiser P. Congenital adrenal hyperplasia due to 21-hydroxylase deficiency. Endocr Rev. 2000;21:245–91.
- Sharp R, Foster M. Clinical utility and full disclosure of genetic results to research participants. Am J Bioeth. 2006;6:42–4.
- Dreger A, Feder E, Tamar-Mattis A. Prenatal dexamethasone for congenital adrenal hyperplasia: an ethics canary in the modern medical mine. J Bioethical Inq. 2012;9:277–94.
- Nimkarn S, New M. Prenatal diagnosis and treatment of congenital adrenal hyperplasia owing to 21-hydroxylase deficiency. Nat Rev Endocrinol. 2007;3:405–13.
- Forest M. Recent advances in the diagnosis and management of congenital adrenal hyperplasia due to 21-hydroxylase deficiency. Hum Reprod Update. 2004;10:469–85.
- Lajic S, Nordenström A, Hirvikoski T. Long-term outcome of prenatal treatment of congenital adrenal hyperplasia. Endocrinol Dev. 2008;13:82–98.
- Joint LWPES/ESPE CAH Working Group. Consensus statement on 21-hydroxylase deficiency from the Lawson Wilkins Pediatric Endocrine Society and the European Society for Paediatric Endocrinology. J Clin Endocrinol Metab. 2002;87:4048–53.
- Wah YM, Leung TY, Cheng YKY, et al. Procedure-related fetal loss following chorionic villus sampling after first-trimester aneuploidy screening. Fetal Diagn Ther. 2017;41:184–90.
- New M, Tong Y, Yuen T, et al. Noninvasive prenatal diagnosis of congenital adrenal hyperplasia using cell-free fetal DNA in maternal plasma. J Clin Endocrinol Metab. 2014;99:E1022–30.
- Tardy-Guidollet V, Menassa R, Costa J, et al. New management strategy of pregnancies at risk of congenital adrenal hyperplasia using fetal sex determination in maternal serum: French cohort of 258 cases (2002–2011). J Clin Endocrinol Metab. 2014;99:1180–8.
- Bustamante-Aragonés A, Rodríguez de Alba M, Perlado S, et al. Non-invasive prenatal diagnosis of single-gene disorders from maternal blood. Gene. 2012;504:144–9.
- Mackie FL, Hemming K, Allen S, et al. The accuracy of cell-free fetal DNA-based non-invasive prenatal testing in singleton pregnancies: a systematic review and bivariate meta-analysis. BJOG Int J Obstet Gynaecol. 2017;124:32–46.
- Grace J, El T, Braude P. Pre-implantation genetic testing. BJOG Int J Obstet Gynaecol. 2004;111:1165–73.
- Brezina P, Kutteh W. Clinical applications of preimplantation genetic testing. BMJ. 2015;350:g7611.
- Harton G, Magli M, Lundin K, et al. ESHRE PGD consortium/embryology special interest group – best practice guidelines for polar body and embryo biopsy for preimplantation genetic diagnosis/screening (PGD/PGS). Hum Reprod Oxf Engl. 2011;26:41–6.